All Stories

  1. Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the First Waves of COVID-19 in North-East Italy

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, September 2024, Bentham Science Publishers

    Andrea Padoan, Mario Plebani, Filippo Ceccato, Mor Peleg Falb

  2. Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, February 2023, Bentham Science Publishers

    Filippo Ceccato

  3. Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2019, De Gruyter

    Filippo Ceccato

  4. Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome

    Article • Clinical Endocrinology, June 2017, Wiley

    Filippo Ceccato, Mario Plebani

  5. Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study

    Article • Hormone and Metabolic Research, May 2016, Thieme Publishing Group

    Filippo Ceccato

  6. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

    Article • European Journal of Endocrinology, May 2016, Bioscientifica

    Filippo Ceccato

  7. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2015, Endocrine Society

    Filippo Ceccato

  8. Clinical use of pasireotide for Cushing's disease in adults

    Article • Therapeutics and Clinical Risk Management, March 2015, Dove Medical Press

    Filippo Ceccato